Trends in primary cerebral lymphoma. NLM AIDSLINE Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Trends in primary cerebral lymphoma.

Br J Cancer. 1994 Oct;70(4):716-8. Unique Identifier : AIDSLINE MED/95001365
Lutz JM; Coleman MP; Thames Cancer Registry, Sutton, Surrey, UK.

Abstract: Primary non-Hodgkin lymphoma of the brain is rare, representing only 1% of all non-Hodgkin lymphomas (NHLs), but its incidence has been increasing rapidly in south-east England since 1985. Among 17,322 cases of NHL registered during the 18 year period 1973-90, there were 210 cases of primary cerebral NHL, of which 179 (86%) were diagnosed in the last third of this period, 1985-90. This increase in cerebral lymphoma is not adequately explained by improvements in the precision of diagnosis or by changes in disease coding or cancer registration practice. While there has also been a rapid increase in Kaposi sarcoma, neither immunosuppression acquired through HIV infection nor the overall trend in non-Hodgkin lymphoma can satisfactorily explain the recent increase in cerebral lymphoma, which affects all ages and both sexes similarly. Other possible causes for a true increase in cerebral lymphoma should be sought.
Keywords: Adolescence Adult Age Factors Aged Brain Neoplasms/*EPIDEMIOLOGY Child Child, Preschool England/EPIDEMIOLOGY Epidemiology/TRENDS Female Human HIV Infections/EPIDEMIOLOGY Incidence Infant Infant, Newborn Lymphoma, Non-Hodgkin's/*EPIDEMIOLOGY Male Middle Age Wales/EPIDEMIOLOGY JOURNAL ARTICLEKWDadolescenceadultagefactorsagedbrainneoplasms/KWDepidemiologychildchild,preschoolengland/epidemiologyepidemiology/trendsfemalehumanhivinfections/epidemiologyincidenceinfantinfant,newbornlymphoma,non-hodgkin's/KWDepidemiologymalemiddleagewales/epidemiologyjournalarticle
950130
M9510823

Copyright © 1995 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .